TeklaLife Sciences Investors (HQL) Financials

HQL Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 402.6 million 666959
2023-03-31 432.7 million 10.0 million
2022-12-31 432.7 million 10.0 million
2022-09-30 414.7 million 16.8 million

HQL Free Cash Flow and Stock based compensation

No data available :(

HQL Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-09-30 -11.5 million
2023-03-31 16.9 million
2022-12-31 16.9 million
2022-09-30 -14.2 million

HQL Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 477 - -
2023-03-31 822 - -
2022-12-31 822 - -
2022-09-30 445 - -

HQL Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 26.8 million
2023-03-31 26.2 million
2022-12-31 26.2 million
2022-09-30 25.7 million

HQL Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - - - -
2023-03-31 - - 1.4 million -
2022-12-31 - - 1.4 million -
2022-09-30 - - 1.4 million -

HQL Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 29.6 million 2.6 million
2023-03-31 9.8 million 2.7 million
2022-12-31 964636 -
2022-09-30 21.7 million 2.6 million

HQL

Price: $12.97

52 week price:
11.34
14.37

Dividend Yield: 0.10%

5-year range yield:
0.10%
11.22%

Forward Dividend Yield: 12.03%

Payout Ratio: 197.47%

Payout Ratio Range:
-2510.95%
197.47%

Dividend Per Share: 1.56 USD

Earnings Per Share: 0.79 USD

P/E Ratio: 17.54

Exchange: NYQ

Sector: Financial Services

Industry: Asset Management

Volume: 93486

Market Capitalization: 355.0 million

Average Dividend Frequency: 4

Years Paying Dividends: 29

DGR3: -2.82%

DGR5: -4.18%

DGR10: 2.24%

DGR20: 12.02%

Links: